Peer Review reports
From: Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
| Original Submission | ||
|---|---|---|
| 16 Feb 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| 28 Mar 2022 | Reviewed | Reviewer Report |
| 21 Jun 2022 | Reviewed | Reviewer Report |
| 17 Aug 2022 | Author responded | Author comments - Lu Wang |
| Resubmission - Version 3 | ||
| 17 Aug 2022 | Submitted | Manuscript version 3 |
| 22 Aug 2022 | Author responded | Author comments - Lu Wang |
| Resubmission - Version 4 | ||
| 22 Aug 2022 | Submitted | Manuscript version 4 |
| 27 Aug 2022 | Author responded | Author comments - Lu Wang |
| Resubmission - Version 5 | ||
| 27 Aug 2022 | Submitted | Manuscript version 5 |
| 7 Sep 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 15 Sep 2022 | Editorially accepted | |
| 1 Oct 2022 | Article published | 10.1186/s12885-022-10110-8 |
You can find further information about peer review here.